506
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Oxidized Regenerated Cellulose Can Reduce Hidden Blood Loss after Total Hip Arthroplasty: A Retrospective Study

ORCID Icon, , &
Pages 716-722 | Received 12 Jan 2018, Accepted 23 Mar 2018, Published online: 11 Apr 2018

REFERENCES

  • Tanaka R, Shigematsu M, Motooka T, Mawatari M, Hotokebuchi T. Factors influencing the improvement of gait ability after total Hip arthroplasty. J Arthroplasty. 2010;25(6):982–985. doi:10.1016/j.arth.2009.06.009. PMID:19646844.
  • Sehat KR, Evans RL, Newman JH. Hidden blood loss following Hip and Knee arthroplasty. Correct management of blood loss should take hidden loss into account. J Bone Joint Surg Br. 2004;86(4):561–565. doi:10.1302/0301-620X.86B4.14508. PMID:15174554.
  • Sehat KR, Evans R, Newman JH. How much blood is really lost in total knee arthroplasty?. Correct blood loss management should take hidden loss into account. Knee. 2000;7(3):151–155. doi:10.1016/S0968-0160(00)00047-8. PMID:10927208.
  • Wu YS, Zhang H, Zheng WH, Feng ZH, Chen ZX, Lin Y. Hidden blood loss and the influential factors after percutaneous kyphoplasty surgery. Eur Spine J. 2017;26(7):1878–1883. doi:10.1007/s00586-017-4950-9. PMID:28102450.
  • Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B. Hidden blood loss after total Hip arthroplasty. J Arthroplasty. 2011;26(7):1100–1105.e1. doi:10.1016/j.arth.2010.11.013. PMID:21256705.
  • Hart A, Khalil JA, Carli A, Huk O, Zukor D, Antoniou J. Blood transfusion in primary total Hip and Knee arthroplasty. Incidence, risk factors, and thirty-day complication rates. J Bone Joint Surg Am. 2014;96(23):1945–1951. doi:10.2106/JBJS.N.00077.
  • Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br. 2008;90(9):1128–1136. doi:10.1302/0301-620X.90B9.21115. PMID:18757950.
  • Vaglio S, Prisco D, Biancofiore G, et al. Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults. Blood transfusion = Trasfusione del sangue. 2016;14(1):23–65. PMID:26710356.
  • Xie J, Hu Q, Ma J, Huang Q, Pei F. Multiple boluses of intravenous tranexamic acid to reduce hidden blood loss and the inflammatory response following enhanced-recovery primary total Hip arthroplasty: a randomised clinical trial. Bone Joint J. 2017;99-b(11):1442–1449. doi:10.1302/0301-620X.99B11.BJJ-2017-0488.R1. PMID:29092982.
  • Zan P, Yao JJ, Fan L, et al. Efficacy of a four-hour drainage clamping technique in the reduction of blood loss following total Hip arthroplasty: a prospective cohort study. Med Sci Monit. 2017;23:2708–2714. doi:10.12659/MSM.904864. PMID:28577369
  • Lee QJ, Chang WY, Wong YC. Blood-sparing efficacy of Oral Tranexamic Acid in primary total Hip arthroplasty. J Arthroplasty. 2017;32(1):139–142. doi:10.1016/j.arth.2016.06.058. PMID:27498390.
  • von Roth P, Perka C, Dirschedl K, et al. Use of Redon drains in primary total Hip arthroplasty has no clinically relevant benefits. Orthopedics. 2012;35(11):e1592–1595. doi:10.3928/01477447-20121023-14. PMID:23127448.
  • Martyn D, Kocharian R, Lim S, et al. Reduction in hospital costs and resource consumption associated with the use of advanced topical hemostats during inpatient procedures. J Med Econ. 2015;18(6):474–481. doi:10.3111/13696998.2015.1017503. PMID:25728820.
  • Wu Y, Wang F, Huang Y. Comparative evaluation of biological performance, biosecurity, and availability of cellulose-based absorbable hemostats. Clin Appl Thromb Hemost. 2018; [Epub ahead of print]. doi:10.1177/1076029617751177. PMID:29363998
  • Achneck HE, Sileshi B, Jamiolkowski RM, Albala DM, Shapiro ML, Lawson JH. A comprehensive review of topical hemostatic agents: efficacy and recommendations for use. Ann Surg. 2010;251(2):217–228. doi:10.1097/SLA.0b013e3181c3bcca. PMID:20010084.
  • Christodoulou A, Samoladas E, Givissis P, Pournaras I. Pulsatile bleeding during closed vertebral biopsy. Acta Orthop Belg. 2007;73(6):778–779. PMID:18260493.
  • Mair H, Kaczmarek I, Oberhoffer M, Groetzner J, Daebritz S, Reichart B. Surgicel Nu-Knit hemostat for bleeding control of fragile sternum. J Thorac Cardiovasc Surg. 2005;130(2):605–606. doi:10.1016/j.jtcvs.2005.04.013. PMID:16077453.
  • Ozkan A, Topkara A, Akbulut M, Ozcan RH. Survival of minced cartilage grafts with comparison Surgicel((R)) original and fibrillar. Aesthetic Plast Surg. 2016;40(4):602–612. doi:10.1007/s00266-016-0661-6. PMID:27286853.
  • Wang CJ, Wang JW, Weng LH, Hsu CC, Huang CC, Yu PC. Prevention of deep-vein thrombosis after total knee arthroplasty in Asian patients. Comparison of low-molecular-weight heparin and indomethacin. J Bone Joint Surg Am. 2004;86-a(1):136–140. doi:10.2106/00004623-200401000-00020. PMID:14711956.
  • Nadler SB, Hidalgo JH, Bloch T. Prediction of blood volume in normal human adults. Surgery. 1962;51(2):224–232. PMID:21936146.
  • Gross JB. Estimating allowable blood loss: corrected for dilution. Anesthesiology. 1983;58(3):277–280. doi:10.1097/00000542-198303000-00016. PMID:6829965.
  • Zhao J, Li J, Zheng W, Liu D, Sun X, Xu W. Low body mass index and blood loss in primary total Hip arthroplasty: results from 236 consecutive ankylosing spondylitis patients. BioMed Res Int. 2014;2014:742393. doi:10.1155/2014/742393. PMID:24959587.
  • Xie J, Hu Q, Huang Q, Ma J, Lei Y, Pei F. Comparison of intravenous versus topical tranexamic acid in primary total Hip and Knee arthroplasty: an updated meta-analysis. Thromb Res. 2017;153:28–36. doi:10.1016/j.thromres.2017.03.009. PMID:28319822.
  • Liu X, Liu J, Sun G. A comparison of combined intravenous and topical administration of tranexamic acid with intravenous tranexamic acid alone for blood loss reduction after total Hip arthroplasty: a meta-analysis. Int J Surg. 2017;41:34–43. doi:10.1016/j.ijsu.2017.03.031. PMID:28336258.
  • Randelli F, Banci L, Ragone V, Pavesi M, Randelli G. Effectiveness of fibrin sealant after cementless total Hip replacement: a double-blind randomized controlled trial. Int J Immunopathol Pharmacol. 2013;26(1):189–197. doi:10.1177/039463201302600118. PMID:23527721.
  • Wei W, Wei B. Comparison of topical and intravenous tranexamic acid on blood loss and transfusion rates in total Hip arthroplasty. J Arthroplasty. 2014;29(11):2113–2116. doi:10.1016/j.arth.2014.07.019. PMID:25155138.
  • Wittmann FW, Ring PA. Reduction in blood loss in total Hip arthroplasty using topical Colgen. J Arthroplasty. 1989;4(3):253–256. doi:10.1016/S0883-5403(89)80021-X. PMID:2795032.
  • Heyse TJ, Haas SB, Drinkwater D, et al. Intraarticular fibrinogen does not reduce blood loss in TKA: a randomized clinical trial. Clin Orthop Relat Res. 2014;472(1):272–276. doi:10.1007/s11999-013-3036-1. PMID:23657879.
  • Emilia M, Luca S, Francesca B, et al. Topical hemostatic agents in surgical practice. Transfus Apheresis Sci. 2011;45(3):305–311. doi:10.1016/j.transci.2011.10.013.
  • Cheng W, Li H, Zheng X, et al. Processing, characterization and hemostatic mechanism of a ultraporous collagen/ORC biodegradable composite with excellent biological effectiveness. Physical Chemistry Chemical Physics: PCCP. 2016;18(42):29183–29191. doi:10.1039/C6CP01374K. PMID:27731435.
  • Finley DS, Lee DI, Eichel L, Uribe CA, McDougall EM, Clayman RV. Fibrin glue-oxidized cellulose sandwich for laparoscopic wedge resection of small renal lesions. J Urol. 2005;173(5):1477–1481. doi:10.1097/01.ju.0000154165.12738.7f. PMID:15821463.
  • Rozanski AT, Viers BR, Liu AG, et al. Oxidized Regenerated Cellulose (Fibrillar) reduces risk of postoperative corporal bleeding following inflatable penile prosthesis surgery. Urology. 2017;108:190–194. doi:10.1016/j.urology.2017.06.002. PMID:28606775.
  • Kim EH, Ahn JY, Chang JH, Kim SH. Management strategies of intercavernous sinus bleeding during transsphenoidal surgery. Acta Neurochir (Wien). 2009;151(7):803–808. doi:10.1007/s00701-009-0356-8. PMID:19404570.
  • Gabay M, Boucher BA. An essential primer for understanding the role of topical hemostats, surgical sealants, and adhesives for maintaining hemostasis. Pharmacotherapy. 2013;33(9):935–955. doi:10.1002/phar.1291. PMID:23686938.
  • Jaspan D, Dandolu V, Miller M, Dunton C. Oxidized regenerated cellulose presenting as a postoperative cyst: a case report. J Reprod Med. 2007;52(12):1109–1110. PMID:18210903.
  • Brodbelt AR, Miles JB, Foy PM, Broome JC. Intraspinal oxidised cellulose (Surgicel) causing delayed paraplegia after thoracotomy–a report of three cases. Ann R Coll Surg Engl. 2002;84(2):97–99. PMID:11995773.
  • Spangler D, Rothenburger S, Nguyen K, Jampani H, Weiss S, Bhende S. In vitro antimicrobial activity of oxidized regenerated cellulose against antibiotic-resistant microorganisms. Surg Infect (Larchmt). 2003;4(3):255–262. doi:10.1089/109629603322419599. PMID:14588160.
  • Kanko M, Liman T, Topcu S. A low-cost and simple method to stop intraoperative leakage-type bleeding: use of the vancomycin-oxidized regenerated cellulose (ORC) sandwich. J Invest Surg. 2006;19(5):323–327. doi:10.1080/08941930600889425. PMID:16966211.
  • Matthew IR, Browne RM, Frame JW, Millar BG. Subperiosteal behaviour of alginate and cellulose wound dressing materials. Biomaterials. 1995;16(4):275–278. doi:10.1016/0142-9612(95)93254-B. PMID:7772666.
  • Saleh A, Hebeish M, Farias-Kovac M, et al. Use of hemostatic agents in Hip and Knee arthroplasty: a critical analysis review. JBJS Rev. 2014;2(1):e4. doi:10.2106/JBJS.RVW.M.00061.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.